Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

References for PMC Articles for PubMed (Select 22573861)

1.

Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.

Gray KK, Worthy MN, Juelich TL, Agar SL, Poussard A, Ragland D, Freiberg AN, Holbrook MR.

PLoS Negl Trop Dis. 2012;6(2):e1529. doi: 10.1371/journal.pntd.0001529. Epub 2012 Feb 28.

2.

Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies.

Fukushi S, Nakauchi M, Mizutani T, Saijo M, Kurane I, Morikawa S.

J Virol Methods. 2012 Mar;180(1-2):68-74. doi: 10.1016/j.jviromet.2011.12.013. Epub 2012 Jan 5.

PMID:
22240075
3.

Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Gommet C, Billecocq A, Jouvion G, Hasan M, Zaverucha do Valle T, Guillemot L, Blanchet C, van Rooijen N, Montagutelli X, Bouloy M, Panthier JJ.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1421. doi: 10.1371/journal.pntd.0001421. Epub 2011 Dec 6.

4.

Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.

Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova ML, Albariño CG, Nichol ST.

J Virol. 2011 Dec;85(24):12901-9. doi: 10.1128/JVI.06046-11. Epub 2011 Oct 5.

5.

Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Jansen van Vuren P, Tiemessen CT, Paweska JT.

PLoS One. 2011;6(9):e25027. doi: 10.1371/journal.pone.0025027. Epub 2011 Sep 16.

6.

Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.

Morrill JC, Peters CJ.

J Infect Dis. 2011 Aug 15;204(4):617-25. doi: 10.1093/infdis/jir354.

7.

DC-SIGN as a receptor for phleboviruses.

Lozach PY, Kühbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A.

Cell Host Microbe. 2011 Jul 21;10(1):75-88. doi: 10.1016/j.chom.2011.06.007.

8.

Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.

Morrill JC, Peters CJ.

J Infect Dis. 2011 Jul 15;204(2):229-36. doi: 10.1093/infdis/jir249.

9.

The pathogenesis of Rift Valley fever.

Ikegami T, Makino S.

Viruses. 2011 May;3(5):493-519. doi: 10.3390/v3050493. Review.

10.

NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62.

Kalveram B, Lihoradova O, Ikegami T.

J Virol. 2011 Jul;85(13):6234-43. doi: 10.1128/JVI.02255-10. Epub 2011 May 4.

11.

Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance.

Carroll SA, Reynes JM, Khristova ML, Andriamandimby SF, Rollin PE, Nichol ST.

J Virol. 2011 Jul;85(13):6162-7. doi: 10.1128/JVI.00335-11. Epub 2011 Apr 20.

12.
13.

Langerhans cells: not your average dendritic cell.

Kaplan DH.

Trends Immunol. 2010 Dec;31(12):437. doi: 10.1016/j.it.2010.10.003. Epub 2010 Nov 12. No abstract available.

14.

The pathogenesis of Rift Valley fever virus in the mouse model.

Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE.

Virology. 2010 Nov 25;407(2):256-67. doi: 10.1016/j.virol.2010.08.016. Epub 2010 Sep 17.

15.

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.

Dungu B, Louw I, Lubisi A, Hunter P, von Teichman BF, Bouloy M.

Vaccine. 2010 Jun 23;28(29):4581-7. doi: 10.1016/j.vaccine.2010.04.085. Epub 2010 May 12.

PMID:
20470792
16.

Rift Valley fever virus: an unrecognized emerging threat?

Mandell RB, Flick R.

Hum Vaccin. 2010 Jul;6(7):597-601.

17.

Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA.

Morrill JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, Terasaki K, Zamoto-Niikura A, Peters CJ, Makino S.

PLoS One. 2010 Apr 1;5(4):e9986. doi: 10.1371/journal.pone.0009986. Erratum in: PLoS One. 2010;5(4). doi: 10.1371/annotation/326c5f5b-3da9-4b0b-b889-28d4f33d2543.

18.

Rift valley fever vaccines.

Ikegami T, Makino S.

Vaccine. 2009 Nov 5;27 Suppl 4:D69-72. doi: 10.1016/j.vaccine.2009.07.046. Review.

19.

Rift Valley fever virus.

Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ.

J Am Vet Med Assoc. 2009 Apr 1;234(7):883-93. doi: 10.2460/javma.234.7.883. Review. No abstract available.

PMID:
19335238
20.

NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F.

J Virol. 2009 May;83(9):4365-75. doi: 10.1128/JVI.02148-08. Epub 2009 Feb 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk